nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—Redness—Cladribine—multiple sclerosis	0.0326	0.0392	CcSEcCtD
Naphazoline—Ocular discomfort—Methotrexate—multiple sclerosis	0.0317	0.0382	CcSEcCtD
Naphazoline—Eye pain—Fingolimod—multiple sclerosis	0.0312	0.0376	CcSEcCtD
Naphazoline—Intraocular pressure increased—Prednisolone—multiple sclerosis	0.027	0.0325	CcSEcCtD
Naphazoline—Intraocular pressure increased—Triamcinolone—multiple sclerosis	0.0248	0.0299	CcSEcCtD
Naphazoline—Intraocular pressure increased—Methylprednisolone—multiple sclerosis	0.0248	0.0298	CcSEcCtD
Naphazoline—Intraocular pressure increased—Dexamethasone—multiple sclerosis	0.0225	0.0271	CcSEcCtD
Naphazoline—Intraocular pressure increased—Betamethasone—multiple sclerosis	0.0225	0.0271	CcSEcCtD
Naphazoline—Endophthalmitis—Betamethasone—multiple sclerosis	0.0208	0.025	CcSEcCtD
Naphazoline—Endophthalmitis—Dexamethasone—multiple sclerosis	0.0208	0.025	CcSEcCtD
Naphazoline—Intraocular pressure increased—Prednisone—multiple sclerosis	0.0196	0.0236	CcSEcCtD
Naphazoline—Keratitis—Prednisolone—multiple sclerosis	0.0183	0.022	CcSEcCtD
Naphazoline—Eye disorder—Fingolimod—multiple sclerosis	0.0182	0.0219	CcSEcCtD
Naphazoline—Endophthalmitis—Prednisone—multiple sclerosis	0.0181	0.0218	CcSEcCtD
Naphazoline—Vision blurred—Fingolimod—multiple sclerosis	0.016	0.0193	CcSEcCtD
Naphazoline—Keratitis—Dexamethasone—multiple sclerosis	0.0153	0.0184	CcSEcCtD
Naphazoline—Keratitis—Betamethasone—multiple sclerosis	0.0153	0.0184	CcSEcCtD
Naphazoline—Mydriasis—Prednisolone—multiple sclerosis	0.0149	0.0179	CcSEcCtD
Naphazoline—Hypertension—Fingolimod—multiple sclerosis	0.0147	0.0176	CcSEcCtD
Naphazoline—Eye disorder—Cladribine—multiple sclerosis	0.0103	0.0124	CcSEcCtD
Naphazoline—Asthenia—Fingolimod—multiple sclerosis	0.00994	0.012	CcSEcCtD
Naphazoline—Erythema—Cladribine—multiple sclerosis	0.00962	0.0116	CcSEcCtD
Naphazoline—Dizziness—Fingolimod—multiple sclerosis	0.00916	0.011	CcSEcCtD
Naphazoline—Headache—Fingolimod—multiple sclerosis	0.00868	0.0104	CcSEcCtD
Naphazoline—Hyperglycaemia—Mitoxantrone—multiple sclerosis	0.00819	0.00986	CcSEcCtD
Naphazoline—Discomfort—Cladribine—multiple sclerosis	0.00809	0.00974	CcSEcCtD
Naphazoline—Drowsiness—Mitoxantrone—multiple sclerosis	0.00809	0.00974	CcSEcCtD
Naphazoline—Eye pain—Dexamethasone—multiple sclerosis	0.00796	0.00959	CcSEcCtD
Naphazoline—Eye pain—Betamethasone—multiple sclerosis	0.00796	0.00959	CcSEcCtD
Naphazoline—Sweating—Mitoxantrone—multiple sclerosis	0.00776	0.00934	CcSEcCtD
Naphazoline—Hyperhidrosis—Cladribine—multiple sclerosis	0.00759	0.00914	CcSEcCtD
Naphazoline—Somnolence—Cladribine—multiple sclerosis	0.00698	0.0084	CcSEcCtD
Naphazoline—Discomfort—Azathioprine—multiple sclerosis	0.00658	0.00792	CcSEcCtD
Naphazoline—Erythema—Mitoxantrone—multiple sclerosis	0.00632	0.00761	CcSEcCtD
Naphazoline—Vision blurred—Mitoxantrone—multiple sclerosis	0.00596	0.00717	CcSEcCtD
Naphazoline—Sweating—Methylprednisolone—multiple sclerosis	0.00584	0.00703	CcSEcCtD
Naphazoline—Asthenia—Cladribine—multiple sclerosis	0.00563	0.00678	CcSEcCtD
Naphazoline—Hyperglycaemia—Betamethasone—multiple sclerosis	0.0056	0.00675	CcSEcCtD
Naphazoline—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.0056	0.00675	CcSEcCtD
Naphazoline—Hypertension—Mitoxantrone—multiple sclerosis	0.00546	0.00657	CcSEcCtD
Naphazoline—Discomfort—Mitoxantrone—multiple sclerosis	0.00532	0.0064	CcSEcCtD
Naphazoline—Dizziness—Cladribine—multiple sclerosis	0.00519	0.00625	CcSEcCtD
Naphazoline—Erythema—Prednisolone—multiple sclerosis	0.00519	0.00625	CcSEcCtD
Naphazoline—Eye disorder—Methylprednisolone—multiple sclerosis	0.00511	0.00615	CcSEcCtD
Naphazoline—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00499	0.00601	CcSEcCtD
Naphazoline—Headache—Cladribine—multiple sclerosis	0.00492	0.00592	CcSEcCtD
Naphazoline—Vision blurred—Prednisolone—multiple sclerosis	0.00489	0.00589	CcSEcCtD
Naphazoline—Hyperglycaemia—Prednisone—multiple sclerosis	0.00488	0.00588	CcSEcCtD
Naphazoline—Erythema—Triamcinolone—multiple sclerosis	0.00477	0.00574	CcSEcCtD
Naphazoline—Erythema—Methylprednisolone—multiple sclerosis	0.00476	0.00573	CcSEcCtD
Naphazoline—Nausea—Cladribine—multiple sclerosis	0.00466	0.00561	CcSEcCtD
Naphazoline—Eye disorder—Betamethasone—multiple sclerosis	0.00465	0.00559	CcSEcCtD
Naphazoline—Eye disorder—Dexamethasone—multiple sclerosis	0.00465	0.00559	CcSEcCtD
Naphazoline—Somnolence—Mitoxantrone—multiple sclerosis	0.00459	0.00552	CcSEcCtD
Naphazoline—Hypertension—Prednisolone—multiple sclerosis	0.00448	0.00539	CcSEcCtD
Naphazoline—Discomfort—Prednisolone—multiple sclerosis	0.00436	0.00525	CcSEcCtD
Naphazoline—Erythema—Dexamethasone—multiple sclerosis	0.00433	0.00521	CcSEcCtD
Naphazoline—Erythema—Betamethasone—multiple sclerosis	0.00433	0.00521	CcSEcCtD
Naphazoline—Dizziness—Azathioprine—multiple sclerosis	0.00422	0.00508	CcSEcCtD
Naphazoline—Hypertension—Triamcinolone—multiple sclerosis	0.00412	0.00496	CcSEcCtD
Naphazoline—Hypertension—Methylprednisolone—multiple sclerosis	0.00411	0.00495	CcSEcCtD
Naphazoline—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00409	0.00493	CcSEcCtD
Naphazoline—Eye disorder—Prednisone—multiple sclerosis	0.00405	0.00487	CcSEcCtD
Naphazoline—Drowsiness—Methotrexate—multiple sclerosis	0.00403	0.00485	CcSEcCtD
Naphazoline—Discomfort—Triamcinolone—multiple sclerosis	0.00401	0.00483	CcSEcCtD
Naphazoline—Discomfort—Methylprednisolone—multiple sclerosis	0.004	0.00482	CcSEcCtD
Naphazoline—Headache—Azathioprine—multiple sclerosis	0.004	0.00481	CcSEcCtD
Naphazoline—Sweating—Methotrexate—multiple sclerosis	0.00387	0.00465	CcSEcCtD
Naphazoline—Nausea—Azathioprine—multiple sclerosis	0.00379	0.00457	CcSEcCtD
Naphazoline—Erythema—Prednisone—multiple sclerosis	0.00377	0.00454	CcSEcCtD
Naphazoline—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00376	0.00453	CcSEcCtD
Naphazoline—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00376	0.00452	CcSEcCtD
Naphazoline—Hypertension—Betamethasone—multiple sclerosis	0.00374	0.0045	CcSEcCtD
Naphazoline—Hypertension—Dexamethasone—multiple sclerosis	0.00374	0.0045	CcSEcCtD
Naphazoline—Asthenia—Mitoxantrone—multiple sclerosis	0.0037	0.00446	CcSEcCtD
Naphazoline—Discomfort—Dexamethasone—multiple sclerosis	0.00364	0.00438	CcSEcCtD
Naphazoline—Discomfort—Betamethasone—multiple sclerosis	0.00364	0.00438	CcSEcCtD
Naphazoline—Vision blurred—Prednisone—multiple sclerosis	0.00355	0.00428	CcSEcCtD
Naphazoline—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00342	0.00411	CcSEcCtD
Naphazoline—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00342	0.00411	CcSEcCtD
Naphazoline—Eye disorder—Methotrexate—multiple sclerosis	0.00338	0.00407	CcSEcCtD
Naphazoline—Hypertension—Prednisone—multiple sclerosis	0.00325	0.00392	CcSEcCtD
Naphazoline—Headache—Mitoxantrone—multiple sclerosis	0.00323	0.00389	CcSEcCtD
Naphazoline—Discomfort—Prednisone—multiple sclerosis	0.00317	0.00382	CcSEcCtD
Naphazoline—Erythema—Methotrexate—multiple sclerosis	0.00315	0.00379	CcSEcCtD
Naphazoline—Nausea—Mitoxantrone—multiple sclerosis	0.00307	0.00369	CcSEcCtD
Naphazoline—Hyperhidrosis—Prednisone—multiple sclerosis	0.00297	0.00358	CcSEcCtD
Naphazoline—Vision blurred—Methotrexate—multiple sclerosis	0.00297	0.00357	CcSEcCtD
Naphazoline—Dizziness—Prednisolone—multiple sclerosis	0.0028	0.00337	CcSEcCtD
Naphazoline—Asthenia—Triamcinolone—multiple sclerosis	0.00279	0.00336	CcSEcCtD
Naphazoline—Asthenia—Methylprednisolone—multiple sclerosis	0.00279	0.00336	CcSEcCtD
Naphazoline—ADRA2A—peripheral nervous system—multiple sclerosis	0.00276	0.128	CbGeAlD
Naphazoline—Headache—Prednisolone—multiple sclerosis	0.00265	0.00319	CcSEcCtD
Naphazoline—Discomfort—Methotrexate—multiple sclerosis	0.00265	0.00319	CcSEcCtD
Naphazoline—Dizziness—Triamcinolone—multiple sclerosis	0.00257	0.0031	CcSEcCtD
Naphazoline—Dizziness—Methylprednisolone—multiple sclerosis	0.00257	0.00309	CcSEcCtD
Naphazoline—Asthenia—Dexamethasone—multiple sclerosis	0.00253	0.00305	CcSEcCtD
Naphazoline—Asthenia—Betamethasone—multiple sclerosis	0.00253	0.00305	CcSEcCtD
Naphazoline—Nausea—Prednisolone—multiple sclerosis	0.00251	0.00303	CcSEcCtD
Naphazoline—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00249	0.00299	CcSEcCtD
Naphazoline—Headache—Triamcinolone—multiple sclerosis	0.00244	0.00294	CcSEcCtD
Naphazoline—Headache—Methylprednisolone—multiple sclerosis	0.00243	0.00293	CcSEcCtD
Naphazoline—Dizziness—Betamethasone—multiple sclerosis	0.00234	0.00281	CcSEcCtD
Naphazoline—Dizziness—Dexamethasone—multiple sclerosis	0.00234	0.00281	CcSEcCtD
Naphazoline—Nausea—Triamcinolone—multiple sclerosis	0.00231	0.00278	CcSEcCtD
Naphazoline—Nausea—Methylprednisolone—multiple sclerosis	0.00231	0.00278	CcSEcCtD
Naphazoline—Somnolence—Methotrexate—multiple sclerosis	0.00229	0.00275	CcSEcCtD
Naphazoline—Headache—Dexamethasone—multiple sclerosis	0.00221	0.00266	CcSEcCtD
Naphazoline—Headache—Betamethasone—multiple sclerosis	0.00221	0.00266	CcSEcCtD
Naphazoline—Asthenia—Prednisone—multiple sclerosis	0.00221	0.00266	CcSEcCtD
Naphazoline—Nausea—Betamethasone—multiple sclerosis	0.0021	0.00253	CcSEcCtD
Naphazoline—Nausea—Dexamethasone—multiple sclerosis	0.0021	0.00253	CcSEcCtD
Naphazoline—Dizziness—Prednisone—multiple sclerosis	0.00203	0.00245	CcSEcCtD
Naphazoline—Headache—Prednisone—multiple sclerosis	0.00193	0.00232	CcSEcCtD
Naphazoline—Asthenia—Methotrexate—multiple sclerosis	0.00184	0.00222	CcSEcCtD
Naphazoline—Nausea—Prednisone—multiple sclerosis	0.00183	0.0022	CcSEcCtD
Naphazoline—NISCH—medulla oblongata—multiple sclerosis	0.00176	0.0818	CbGeAlD
Naphazoline—Dizziness—Methotrexate—multiple sclerosis	0.0017	0.00205	CcSEcCtD
Naphazoline—NISCH—midbrain—multiple sclerosis	0.00161	0.0747	CbGeAlD
Naphazoline—Headache—Methotrexate—multiple sclerosis	0.00161	0.00194	CcSEcCtD
Naphazoline—NISCH—spinal cord—multiple sclerosis	0.00157	0.0729	CbGeAlD
Naphazoline—Nausea—Methotrexate—multiple sclerosis	0.00153	0.00184	CcSEcCtD
Naphazoline—NISCH—cerebellum—multiple sclerosis	0.00125	0.0578	CbGeAlD
Naphazoline—ADRA1A—brainstem—multiple sclerosis	0.00121	0.0562	CbGeAlD
Naphazoline—NISCH—brain—multiple sclerosis	0.00101	0.047	CbGeAlD
Naphazoline—ADRA2C—medulla oblongata—multiple sclerosis	0.000806	0.0374	CbGeAlD
Naphazoline—ADRA2C—midbrain—multiple sclerosis	0.000737	0.0341	CbGeAlD
Naphazoline—ADRA2C—spinal cord—multiple sclerosis	0.000719	0.0333	CbGeAlD
Naphazoline—ADRA2A—medulla oblongata—multiple sclerosis	0.000643	0.0298	CbGeAlD
Naphazoline—ADRA1A—nervous system—multiple sclerosis	0.000635	0.0295	CbGeAlD
Naphazoline—ADRA1A—central nervous system—multiple sclerosis	0.000612	0.0284	CbGeAlD
Naphazoline—ADRA2C—nervous system—multiple sclerosis	0.000606	0.0281	CbGeAlD
Naphazoline—ADRA1A—cerebellum—multiple sclerosis	0.000598	0.0277	CbGeAlD
Naphazoline—ADRA2A—midbrain—multiple sclerosis	0.000588	0.0272	CbGeAlD
Naphazoline—ADRA2C—central nervous system—multiple sclerosis	0.000583	0.027	CbGeAlD
Naphazoline—ADRA2A—spinal cord—multiple sclerosis	0.000573	0.0266	CbGeAlD
Naphazoline—ADRA2C—cerebellum—multiple sclerosis	0.00057	0.0264	CbGeAlD
Naphazoline—ADRA1A—brain—multiple sclerosis	0.000486	0.0225	CbGeAlD
Naphazoline—ADRA2A—nervous system—multiple sclerosis	0.000483	0.0224	CbGeAlD
Naphazoline—ADRA2A—central nervous system—multiple sclerosis	0.000465	0.0216	CbGeAlD
Naphazoline—ADRA2C—brain—multiple sclerosis	0.000463	0.0215	CbGeAlD
Naphazoline—ADRA2A—cerebellum—multiple sclerosis	0.000455	0.0211	CbGeAlD
Naphazoline—ADRA2A—brain—multiple sclerosis	0.000369	0.0171	CbGeAlD
Naphazoline—ADRA1A—Signaling Pathways—S1PR1—multiple sclerosis	0.000186	0.00126	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—GPR65—multiple sclerosis	0.000183	0.00124	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CCR2—multiple sclerosis	0.000183	0.00124	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—PTGER4—multiple sclerosis	0.000182	0.00123	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—GPC5—multiple sclerosis	0.000181	0.00122	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—RGS1—multiple sclerosis	0.000181	0.00122	CbGpPWpGaD
Naphazoline—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.00018	0.00122	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—POMC—multiple sclerosis	0.00018	0.00122	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000179	0.00121	CbGpPWpGaD
Naphazoline—ADRA2B—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000176	0.00119	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CXCR3—multiple sclerosis	0.000176	0.00119	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—CCL2—multiple sclerosis	0.000176	0.00119	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000175	0.00119	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000175	0.00118	CbGpPWpGaD
Naphazoline—ADRA2A—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.000175	0.00118	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—CCR5—multiple sclerosis	0.000174	0.00118	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—CNR1—multiple sclerosis	0.000174	0.00118	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—S1PR1—multiple sclerosis	0.000173	0.00117	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—GPR65—multiple sclerosis	0.000171	0.00116	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CCR2—multiple sclerosis	0.000171	0.00116	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000169	0.00114	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CNR1—multiple sclerosis	0.000169	0.00114	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—GPC5—multiple sclerosis	0.000168	0.00114	CbGpPWpGaD
Naphazoline—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.000168	0.00114	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCR1—multiple sclerosis	0.000168	0.00114	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CXCL13—multiple sclerosis	0.000168	0.00114	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—POMC—multiple sclerosis	0.000168	0.00114	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000167	0.00113	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—RRM1—multiple sclerosis	0.000166	0.00113	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CCL3—multiple sclerosis	0.000165	0.00112	CbGpPWpGaD
Naphazoline—ADRA2C—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000165	0.00111	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CCR2—multiple sclerosis	0.000165	0.00111	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—CCL2—multiple sclerosis	0.000164	0.00111	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000163	0.0011	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000159	0.00108	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—RGS1—multiple sclerosis	0.000158	0.00107	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CNR1—multiple sclerosis	0.000158	0.00107	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000157	0.00106	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCR1—multiple sclerosis	0.000157	0.00106	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CXCL13—multiple sclerosis	0.000157	0.00106	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000156	0.00106	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—IL2RA—multiple sclerosis	0.000154	0.00104	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CXCR3—multiple sclerosis	0.000154	0.00104	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CCL3—multiple sclerosis	0.000153	0.00104	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CCR2—multiple sclerosis	0.000153	0.00103	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CXCL10—multiple sclerosis	0.000152	0.00103	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CNR1—multiple sclerosis	0.000152	0.00103	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—GPR65—multiple sclerosis	0.00015	0.00101	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CCR2—multiple sclerosis	0.000149	0.00101	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PTGER4—multiple sclerosis	0.000148	0.001	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000147	0.000995	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—RGS1—multiple sclerosis	0.000147	0.000993	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—POMC—multiple sclerosis	0.000147	0.000992	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—ALB—multiple sclerosis	0.000146	0.000991	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—CCL5—multiple sclerosis	0.000144	0.000975	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—CCL2—multiple sclerosis	0.000143	0.000971	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CXCR3—multiple sclerosis	0.000143	0.000966	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CXCL10—multiple sclerosis	0.000142	0.000961	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CNR1—multiple sclerosis	0.000141	0.000955	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—GPR65—multiple sclerosis	0.000139	0.000942	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CCR2—multiple sclerosis	0.000139	0.00094	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CNR1—multiple sclerosis	0.000138	0.000933	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCR1—multiple sclerosis	0.000137	0.000927	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CXCL13—multiple sclerosis	0.000137	0.000927	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—ALB—multiple sclerosis	0.000137	0.000925	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000137	0.000925	CbGpPWpGaD
Naphazoline—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.000136	0.000922	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—POMC—multiple sclerosis	0.000136	0.000922	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—CCL5—multiple sclerosis	0.000135	0.000911	CbGpPWpGaD
Naphazoline—ADRA2A—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000134	0.000905	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—CCL2—multiple sclerosis	0.000133	0.000902	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CCL5—multiple sclerosis	0.000131	0.000886	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—CCR5—multiple sclerosis	0.00013	0.000879	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CNR1—multiple sclerosis	0.000128	0.000867	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000128	0.000866	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCR1—multiple sclerosis	0.000127	0.000861	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CXCL13—multiple sclerosis	0.000127	0.000861	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000127	0.00086	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000124	0.00084	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CCL5—multiple sclerosis	0.000122	0.000827	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—CCR5—multiple sclerosis	0.000121	0.000821	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00012	0.000809	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCL3—multiple sclerosis	0.00012	0.000809	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—IL2—multiple sclerosis	0.000119	0.000803	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CCR5—multiple sclerosis	0.000118	0.000798	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CCL5—multiple sclerosis	0.000118	0.000796	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—BCHE—multiple sclerosis	0.000118	0.000796	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—IL2RA—multiple sclerosis	0.000116	0.000786	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000115	0.000781	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PTGER4—multiple sclerosis	0.000115	0.000779	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PGR—multiple sclerosis	0.000113	0.000767	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000113	0.000765	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCL3—multiple sclerosis	0.000112	0.000756	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CXCR3—multiple sclerosis	0.000111	0.000752	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—ALB—multiple sclerosis	0.000111	0.000752	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—IL2—multiple sclerosis	0.000111	0.00075	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CCR5—multiple sclerosis	0.00011	0.000745	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CD28—multiple sclerosis	0.00011	0.000745	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CCL5—multiple sclerosis	0.000109	0.00074	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—IL2RA—multiple sclerosis	0.000109	0.000735	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCR2—multiple sclerosis	0.000108	0.000732	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PTGER4—multiple sclerosis	0.000107	0.000727	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	0.000107	0.000723	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000106	0.000718	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PGR—multiple sclerosis	0.000106	0.000716	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000104	0.000707	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CXCR3—multiple sclerosis	0.000104	0.000702	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CD28—multiple sclerosis	0.000103	0.000696	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—POMC—multiple sclerosis	0.000101	0.000687	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCR2—multiple sclerosis	0.000101	0.000683	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CNR1—multiple sclerosis	9.97e-05	0.000675	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CCL5—multiple sclerosis	9.93e-05	0.000672	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CCR5—multiple sclerosis	9.85e-05	0.000667	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	9.76e-05	0.000661	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	9.71e-05	0.000657	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	9.63e-05	0.000652	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—BCHE—multiple sclerosis	9.56e-05	0.000647	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	9.49e-05	0.000642	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—POMC—multiple sclerosis	9.48e-05	0.000642	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	9.39e-05	0.000636	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CNR1—multiple sclerosis	9.32e-05	0.000631	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—TGFB1—multiple sclerosis	9.26e-05	0.000627	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	9.25e-05	0.000626	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—POMC—multiple sclerosis	9.21e-05	0.000624	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—MAPK1—multiple sclerosis	9.08e-05	0.000615	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	9.07e-05	0.000614	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	9.07e-05	0.000614	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CCL2—multiple sclerosis	9.02e-05	0.00061	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—IL2—multiple sclerosis	9.01e-05	0.00061	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	8.99e-05	0.000608	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CXCL10—multiple sclerosis	8.98e-05	0.000608	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	8.94e-05	0.000605	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	8.83e-05	0.000597	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	8.82e-05	0.000597	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	8.73e-05	0.000591	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—TGFB1—multiple sclerosis	8.65e-05	0.000585	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—POMC—multiple sclerosis	8.61e-05	0.000583	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	8.6e-05	0.000582	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—MAPK1—multiple sclerosis	8.48e-05	0.000574	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	8.43e-05	0.000571	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CCL2—multiple sclerosis	8.42e-05	0.00057	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CXCL10—multiple sclerosis	8.39e-05	0.000568	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	8.35e-05	0.000565	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	8.29e-05	0.000561	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	8.2e-05	0.000555	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—TYK2—multiple sclerosis	8.19e-05	0.000554	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	8.14e-05	0.000551	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CD86—multiple sclerosis	7.85e-05	0.000532	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCL5—multiple sclerosis	7.73e-05	0.000523	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	7.7e-05	0.000521	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—TYK2—multiple sclerosis	7.65e-05	0.000518	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	7.57e-05	0.000512	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	7.52e-05	0.000509	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—IL2—multiple sclerosis	7.5e-05	0.000508	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	7.36e-05	0.000498	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CD86—multiple sclerosis	7.33e-05	0.000496	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	7.33e-05	0.000496	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCL5—multiple sclerosis	7.22e-05	0.000489	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	7.16e-05	0.000485	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—APOE—multiple sclerosis	7.08e-05	0.000479	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	7.02e-05	0.000475	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—IL2—multiple sclerosis	7.01e-05	0.000474	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	6.99e-05	0.000473	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	6.96e-05	0.000471	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	6.89e-05	0.000466	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	6.86e-05	0.000465	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	6.84e-05	0.000463	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	6.81e-05	0.000461	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	6.81e-05	0.000461	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SPP1—multiple sclerosis	6.69e-05	0.000453	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	6.68e-05	0.000452	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCR5—multiple sclerosis	6.51e-05	0.00044	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	6.41e-05	0.000434	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL2RA—multiple sclerosis	6.41e-05	0.000434	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—IL2—multiple sclerosis	6.36e-05	0.000431	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	6.34e-05	0.000429	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	6.31e-05	0.000427	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	6.21e-05	0.00042	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	6.13e-05	0.000415	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—POMC—multiple sclerosis	6.08e-05	0.000412	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	5.96e-05	0.000403	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	5.92e-05	0.000401	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	5.87e-05	0.000397	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	5.85e-05	0.000396	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—APOE—multiple sclerosis	5.75e-05	0.000389	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	5.73e-05	0.000388	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	5.69e-05	0.000385	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	5.69e-05	0.000385	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	5.6e-05	0.000379	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	5.56e-05	0.000376	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ALB—multiple sclerosis	5.54e-05	0.000375	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	5.44e-05	0.000368	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	5.43e-05	0.000368	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	5.35e-05	0.000362	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	5.33e-05	0.00036	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	5.28e-05	0.000358	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	5.21e-05	0.000353	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	5.21e-05	0.000352	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	5.17e-05	0.00035	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	5.17e-05	0.00035	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	5.08e-05	0.000344	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	4.97e-05	0.000337	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—POMC—multiple sclerosis	4.94e-05	0.000334	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	4.87e-05	0.000329	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	4.84e-05	0.000327	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	4.81e-05	0.000325	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	4.68e-05	0.000317	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	4.52e-05	0.000306	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ALB—multiple sclerosis	4.5e-05	0.000305	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	4.44e-05	0.000301	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	4.35e-05	0.000294	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	4.35e-05	0.000294	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	4.25e-05	0.000288	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	4.13e-05	0.00028	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	4.04e-05	0.000273	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	4.02e-05	0.000272	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	4e-05	0.000271	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	3.95e-05	0.000268	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	3.95e-05	0.000267	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	3.81e-05	0.000258	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	3.76e-05	0.000254	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	3.74e-05	0.000253	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	3.67e-05	0.000248	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	3.56e-05	0.000241	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	3.39e-05	0.000229	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	3.29e-05	0.000222	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	3.27e-05	0.000221	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	3.16e-05	0.000214	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	3.15e-05	0.000213	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	3.14e-05	0.000212	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	3.11e-05	0.00021	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	3.08e-05	0.000208	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	3.05e-05	0.000207	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	3.04e-05	0.000206	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	2.94e-05	0.000199	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	2.93e-05	0.000198	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	2.89e-05	0.000196	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	2.88e-05	0.000195	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	2.76e-05	0.000187	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	2.57e-05	0.000174	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	2.57e-05	0.000174	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	2.56e-05	0.000173	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	2.51e-05	0.00017	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	2.39e-05	0.000162	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	2.38e-05	0.000161	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	2.37e-05	0.00016	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	2.34e-05	0.000158	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	2.21e-05	0.00015	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	1.93e-05	0.000131	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	1.79e-05	0.000121	CbGpPWpGaD
